Your browser doesn't support javascript.
loading
Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial.
Stenmark Tullberg, Axel; Sjöström, Martin; Tran, Lena; Niméus, Emma; Killander, Fredrika; Kovács, Anikó; Lundstedt, Dan; Holmberg, Erik; Karlsson, Per.
Afiliación
  • Stenmark Tullberg A; Department of Oncology, University of Gothenburg Institute of Clinical Sciences, Goteborg, Sweden axel.tullberg@gu.se.
  • Sjöström M; Department of Radiation Oncology, UCSF, San Francisco, California, USA.
  • Tran L; Department of Clinical Sciences Lund, Oncology/Pathology and Surgery, Lund University, Lund, Sweden.
  • Niméus E; Department of Clinical Sciences Lund, Oncology/Pathology and Surgery, Lund University, Lund, Sweden.
  • Killander F; Department of Clinical Sciences Lund, Oncology/Pathology and Surgery, Lund University, Lund, Sweden.
  • Kovács A; Department of Surgery, Skåne University Hospital, Lund, Sweden.
  • Lundstedt D; Department of Clinical Sciences Lund, Oncology/Pathology and Surgery, Lund University, Lund, Sweden.
  • Holmberg E; Department of Oncology, Skåne University Hospital, Lund, Sweden.
  • Karlsson P; Department of Clinical Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden.
J Immunother Cancer ; 11(5)2023 05.
Article en En | MEDLINE | ID: mdl-37208129
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: Suecia